Walter E. Aulitzky

Robert Bosch Hospital

Research Area

Biography

Walter E. Aulitzky has not added Biography.
If you are Walter E. Aulitzky and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study. Breast cancer research : BCR\| PubMed ID: 15987433	2005
Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC cancer\| PubMed ID: 16603054	2006
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark). Therapeutics and clinical risk management\| PubMed ID: 18728706	2008
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC cancer\| PubMed ID: 19077243	2008
Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Molecular cancer\| PubMed ID: 20579391	2010
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PloS one\| PubMed ID: 21532991	2011
Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis. PloS one\| PubMed ID: 21949869	2011
A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC. Annals of surgical oncology\| PubMed ID: 26350370	2015
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest. Cancer research\| PubMed ID: 27013194	2016
Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma. British journal of haematology\| PubMed ID: 28295185	2017
Burkitt lymphoma and diffuse large B-cell lymphoma: a unique case of a composite lymphoma of different clonal origin. Leukemia & lymphoma\| PubMed ID: 28583033	2018
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA. Journal of hematology & oncology\| PubMed ID: 30180865	2018
Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies. European journal of haematology\| PubMed ID: 30347469	2019
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. Journal of experimental & clinical cancer research : CR\| PubMed ID: 31676012	2019
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell death & disease\| PubMed ID: 31699970	2019
The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA. Cell death & disease\| PubMed ID: 32839432	2020
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study. Haematologica\| PubMed ID: 34047178	2021
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers. Cancer discovery\| PubMed ID: 34112699	2021
The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA. Cell death discovery\| PubMed ID: 35443750	2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature communications\| PubMed ID: 36443319	2022
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature communications\| PubMed ID: 36627302	2023
Perfusion Air Culture of Precision-Cut Tumor Slices: An Ex Vivo System to Evaluate Individual Drug Response under Controlled Culture Conditions. Cells\| PubMed ID: 36899943	2023
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Cell death & disease\| PubMed ID: 38658567	2024
BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains. EMBO reports\| PubMed ID: 39048751	2024